FDA Investigator Christina J Sauder, PhD

Christina J Sauder, PhD has inspections in 2 countries as of 21 Mar 2023. Christina J Sauder, PhD has collaborated with a combinined 1595 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
3
Last Inspection Date:
21 Mar 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America, Canada
Co-Investigator(s):
Alla Kachko, PhD, Anastasia I Offordile, Anissa M Cheung, Anita R Michael, Anita Verma, Ann L Demarco, Ann Marie Montemurro, Ann Marie Schofield, Audrey Thereset Uy, Brentley S Collins, Brian S Keefer, Burnell M Henry, CDR Jeremy L Wally, PhD, Chao Ming Tsai, Christian D Lynch (CDL), Christopher J Adams, Craig D Zagata, Cynthia Jim, CSO, Dave Hafner, David J Hafner, Debra J Bennett, Debra L Pagano, Diana Kouiavskaia, Donald L Lech, Eileen A Liu, Ellen Huang, Eric Peng, Gene D Arcy, Hala L Selby, Haruhiko Murata, Helen B Ricalde, J David Doleski, Jacqueline Mdiaz Albertini, James E Keller, PhD, James M Mason, James R Evans, Jennifer L Bridgewater, Joan A Loreng, Joan Adamo, Joan Johnson, Joanne M Hajoway, Joseph George, Julianne C Mccullough, Julie D Bringger, Junho Pak, Karyn M Campbell, Kathleen B Mihalik, Kathryn Carbone, MD, Kelly N Kerr, Kenneth M Gordon, Kristen D Evans, LCDR Margaret E Digennaro, Leslie D Wagner, Linda Thai, Lisa Feela, Lisa M Bellows, LT John M Mastalski, Marian E Major, PhD, Michael Curbag, Michael Gurbarg, Michele L Forster, PhD, Mihaly S Ligmond, Nancy T Waites, Omotunde O Osunsanmi, Paul W Keller, Paula A Trost, Prabhu P Raju, Ramon E Martinez, Rebecca K Olin, Robert B Shibuya, MD, Robert D Tollefsen, Roger F Zabinski, Ronald E Lundquist, Rose M Ashley, Scott E Norris, Sean R Bryd, Sheila Dreher Lesnick, Shuang Tang, Simone E Pitts, Stephanie Mangigian, MS/OSH, RN, Stephen D Brown, Steven A Rubin, Steven C Derrick, Susan F Laska, MS, Susan M Jackson, Tammy L Chavis, Tina Buecklein, Tina S Roecklein, Vlada Matusovsky, Wei Wang, PhD, Xiao Wang

Christina J Sauder, PhD's Documents

Publish Date Document Type Title
February, 2013 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2013-02-06
September, 2017 FDA 483 Sanofi Pasteur Limited - Form 483, 2017-09-22
September, 2013 FDA 483 Response Sanofi Pasteur Limited - Form 483R, 2013-10-11
September, 2013 FDA 483 Sanofi Pasteur Limited - Form 483, 2013-09-20

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more